Renminbi Shift: From Potential to Practicality
An independent survey conducted by FinanceAsia of institutions across Asia Pacific explores how the role of the RMB is evolving in a dynamic financial landscape.
GlaxoSmithKline (GSK) on Monday became the latest multinational to boost its investments in India, with a £629 million ($1 billion) offer to increase its stake in its India-listed drug unit
Registered users get 2 free articles in 30 days.
Subscribers have full unlimited access to FinanceAsia.
Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.
Questions?
See here for more information on licences and prices, or contact [email protected].